ORG Wealth Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Buy
3,580
+541
+18% +$71.3K 0.07% 153
2026
Q1
$424K Buy
3,039
+325
+12% +$45.5K 0.08% 147
2025
Q4
$333K Buy
2,714
+35
+1% +$4.25K 0.08% 157
2025
Q3
$297K Buy
2,679
+707
+36% +$80.4K 0.06% 164
2025
Q2
$220K Buy
1,972
+640
+48% +$68.1K 0.05% 173
2025
Q1
$148K Sell
1,332
-1,069
-45% -$110K 0.05% 213
2024
Q4
$222K Buy
2,401
+1,089
+83% +$98.1K 0.07% 117
2024
Q3
$110K Buy
+1,312
New +$100K 0.04% 175

Other funds holding GILD

ORG Wealth Partners's GILD Position: Q2 2026 in Review

ORG Wealth Partners increased its Gilead Sciences (GILD) stake by 18% in Q2 2026, buying an estimated $71.3K and bringing the position to 3,580 shares worth $452K. The position accounts for 0.07% of the portfolio, ranked #153.

ORG Wealth Partners first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • ORG Wealth Partners held 3,580 shares of Gilead Sciences worth $452K as of Q2 2026.
  • ORG Wealth Partners bought 541 Gilead Sciences shares in Q2 2026, an estimated $71.3K.
  • Gilead Sciences made up 0.07% of ORG Wealth Partners's portfolio in Q2 2026, its #153 holding.
  • ORG Wealth Partners first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.